Last edition
News about Global Pharma
Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from the U.S. Food and Drug Administration (FDA) to initiate an international multicenter Phase 2 clinical trial.
Global Pharma | 12/02/2025 | By Manvi | 423
Alloy Therapeutics and Pfizer to Develop New Antibody Discovery Platform
Pfizer and Alloy have collaborated on various antibody discovery efforts, including the use of Alloy's ATX-CLC platform.
Global Pharma | 12/02/2025 | By Aishwarya | 240
Novartis to Acquire Anthos Therapeutics for USD 925 Million Upfront
Anthos Therapeutics, launched by Blackstone Life Sciences and Novartis in 2019, has advanced abelacimab through clinical development under a license from Novartis.
Global Pharma | 12/02/2025 | By Aishwarya | 451
Everest Group Recognises Indegene as Front-Runner in GenAI Life Sciences Market Adoption
The report highlights how Indegene’s holistic GenAI strategy and enterprise-grade, production-ready solutions are helping life sciences companies streamline operations and realize strong productivity improvements across several use cases, spanning the clinical, medical and commercial elements of the life sciences value chain.
Global Pharma | 12/02/2025 | By Aishwarya | 266
Synexa Life Sciences Achieves 'My Green Lab Certification'
Synexa Life Sciences, a global provider of biomarker and bioanalytical solutions to the pharmaceutical, biotech, and CRO industries, has achieved the My Green Lab Certification at the highest ‘Green’ level at its Cape Town, South Africa facility.
Global Pharma | 11/02/2025 | By Manvi | 422
Frontier Scientific Begins Construction of cGMP Facilities at Wilmington Airport
Frontier Scientific Solutions announce that construction of its state-of-the-art cGMP temperature-controlled facilities at Wilmington International Airport (ILM) is in full swing with the first vertical structures being installed.
Global Pharma | 11/02/2025 | By Manvi | 219
Recipharm Expands Aseptic Filling Capabilities for Process Development and Clinical Supply
The system offers unmatched flexibility, featuring interchangeable modules that support various product types, such as syringes and vials.
Global Pharma | 11/02/2025 | By Aishwarya | 562
Accord BioPharma Signs Exclusive US Licensing Deal with Bio-Thera for BAT2506
BAT2506 is a proposed golimumab biosimilar developed by Bio-Thera. Golimumab, a human monoclonal antibody, inhibits the biological activity of tumor necrosis factor alpha (TNF-alpha).
Global Pharma | 11/02/2025 | By Aishwarya | 766
Cosette Pharmaceuticals Welcomes Vincent Colicchio as Senior Vice President of Operations
In this role, Vin will lead Cosette’s manufacturing, global supply chain, and operational strategy, ensuring efficiency, and supply continuity as the company continues its strong trajectory of growth and transformation.
Global Pharma | 11/02/2025 | By Aishwarya | 510
US FDA Approves Abbvie's EMBLAVEO
AbbVie announced that the US Food and Drug Administration (FDA) has approved EMBLAVEO™ (aztreonam and avibactam), as the first and only fixed-dose, intravenous, monobactam/β-lactamase inhibitor combination antibiotic.
Global Pharma | 10/02/2025 | By Manvi | 566
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy